| Investigating the cytotoxic effects of the venom proteome of two species of the Viperidae family (Cerastes cerastes and Cryptelytrops purpureomaculatus) from various habitats CS Ozverel, M Damm, BF Hempel, B Göçmen, R Sroka, RD Süssmuth, ... Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology …, 2019 | 28 | 2019 |
| Chemical composition and biological activities of Cypriot propolis A Nalbantsoy, NB Sarıkahya, CS Özverel, AB Barlas, D Kırcı, İH Akgün, ... Journal of Apicultural Research 61 (2), 233-245, 2022 | 13 | 2022 |
| Comparative evaluation of low-level laser therapy on proliferation of long-term cryopreserved human dental pulp cells isolated from deciduous and permanent teeth A İslam, CS Özverel, HG Yilmaz Lasers in Medical Science 36 (2), 421-427, 2021 | 13 | 2021 |
| Investigation of the combination of anti-PD-L1 mAb with HER2/neu-loaded dendritic cells and QS-21 saponin adjuvant: effect against HER2 positive breast cancer in mice CS Özverel, Y Uyanikgil, İ Karaboz, A Nalbantsoy Immunopharmacology and immunotoxicology 42 (4), 346-357, 2020 | 8 | 2020 |
| The effects of mesenchymal stem cells on the IDO, HLA-G and PD-L1 expression of breast tumor cells MDA-MB-231 and MCF-7 RBÖ Özdemir, AT Özdemir, C Kırmaz, Mİ Tuğlu, Ö Şenol, CS Özverel, ... Archives of Clinical and Experimental Medicine 4 (3), 132-137, 2019 | 7 | 2019 |
| Evaluation of antibacterial and antifungal effects of calcium hydroxide mixed with two different essential oils G Cosan, CS Ozverel, D Yigit Hanoglu, KHC Baser, YM Tunca Molecules 27 (9), 2635, 2022 | 6 | 2022 |
| Designing in-house SARS-CoV-2 RT-qPCR assay for variant of concerns MC Ergoren, G Tuncel, CS Ozverel, T Sanlidag Global Medical Genetics 9 (03), 252-257, 2022 | 4 | 2022 |
| Awareness and perception of dentistry students studying in Cyprus regarding COVID-19: A cross-sectional study. CS Özverel, S Kurtulmus-Yilmaz Journal of Contemporary Medical Sciences 6 (5), 2020 | 4 | 2020 |
| Novel treatment strategies in cancer immunotherapy CS OZVEREL, İ KARABOZ, A NALBANTSOY Acta Biologica Turcica 30 (2), 36-51, 2017 | 4 | 2017 |
| Impact of SARS-CoV-2 Delta and Omicron variants on viral burden and cycle threshold in BNT162b2-vaccinated 12–18 years group MC Ergoren, K Komurcu, G Tuncel, G Akan, CS Ozverel, C Dalkan, ... Brazilian Journal of Microbiology 53 (4), 1937-1940, 2022 | 3 | 2022 |
| The biostimulative effectiveness of photobiomodulation therapy application on thawed dental pulp stem cells CS Özverel, A İslam, HG Yılmaz Journal of Innovative Optical Health Sciences 14 (03), 2150006, 2021 | 2 | 2021 |
| A co-culture study to determine the supportive role of probiotics on immune system against cancer cells A Nalbantsoy, CS Özverel, D Kışla Food and Health 6 (4), 287-298, 2020 | 2 | 2020 |
| A single antiviral for a triple epidemic: is it possible? N Sultanoglu, E Erdag, CS Ozverel Future Virology 18 (10), 633-642, 2023 | 1 | 2023 |
| Effect of the application of a hydrogen peroxide home bleaching agent on the cytotoxicity of different CAD-CAM restorative materials CS Ozverel, S Kurtulmus-Yilmaz Dental and medical problems 60 (2), 311-320, 2023 | 1 | 2023 |
| Exosome mimetic nanovesicles; are they next best alterna‑tive therapeutic approach combating cancer CS Ozverel Cyprus J Med Sci 5 (4), 361-4, 2020 | 1 | 2020 |
| Computational analysis of 3D printing: Selecting the better among newly released materials E Namsoy, IS Sadikoglu, CS Ozverel, E Erdag European Journal of Oral Sciences 132 (3), e12987, 2024 | | 2024 |
| Ruthenium compounds: Are they the next‐era anticancer agents? SB Kavukcu, CS Özverel, N Kıyak, HS Vatansever, H Türkmen Applied Organometallic Chemistry, e7363, 2024 | | 2024 |
| Investigation of the Molecular Interactions of Vaccine Adjuvants: Can a Strategic Trio of Toll-like Receptor Agonists Enhance Efficacy in a Multifaceted Approach? CS Ozverel, E Erdag Biomedical and Biotechnology Research Journal (BBRJ) 8 (1), 27-36, 2024 | | 2024 |
| Comparison of the Rapid Antigen Test to RT-qPCR in Diagnosis of SARS-CoV-2: A University Experience in Northern Cyprus E Güler, F Taner, E Şanlıdağ, P Tulay, MC Ergoren, B Baddal, CS Özverel, ... Clinical and Experimental Health Sciences 13 (3), 525-529, 2023 | | 2023 |
| Is the BNT162b2 vaccine still effective against the latest variant: XBB. 1.5? E Erdag, N Sultanoglu, CS Ozverel Nigerian Journal of Clinical Practice 26 (10), 1519-1524, 2023 | | 2023 |
